115 related articles for article (PubMed ID: 11762561)
1. Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers.
Shah AK; Laboy-Goral L; Scott N; Morse T; Apseloff G
J Clin Pharmacol; 2001 Dec; 41(12):1339-44. PubMed ID: 11762561
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and safety of single escalating oral doses of eletriptan.
Shah AK; Harris SC; Greenhalgh C; Morganroth J
J Clin Pharmacol; 2002 May; 42(5):520-7. PubMed ID: 12017346
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration.
Milton KA; Scott NR; Allen MJ; Abel S; Jenkins VC; James GC; Rance DJ; Eve MD
J Clin Pharmacol; 2002 May; 42(5):528-39. PubMed ID: 12017347
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects.
Kim YK; Shin KH; Alderman J; Yu KS; Jang IJ; Lee S
Drug Des Devel Ther; 2018; 12():331-337. PubMed ID: 29497279
[TBL] [Abstract][Full Text] [Related]
5. The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females.
Kamimori GH; Joubert A; Otterstetter R; Santaromana M; Eddington ND
Eur J Clin Pharmacol; 1999 Aug; 55(6):445-9. PubMed ID: 10492057
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of eletriptan 20 mg, 40 mg and 80 mg in Japanese migraineurs.
Eletriptan Steering Committee in Japan
Cephalalgia; 2002 Jul; 22(6):416-23. PubMed ID: 12133040
[TBL] [Abstract][Full Text] [Related]
7. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
[TBL] [Abstract][Full Text] [Related]
8. Safety, tolerability, and pharmacokinetics of a novel, selective antiprogestagen (Org 31710) in healthy male volunteers.
Mulders TM; Mink CP; Bobbink IW; Bennink HJ
Contraception; 1998 Jul; 58(1):39-44. PubMed ID: 9743895
[TBL] [Abstract][Full Text] [Related]
9. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
10. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
Grimes EM; Thompson IE; Taymor ML
Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
[TBL] [Abstract][Full Text] [Related]
11. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
12. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
13. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles.
Capobianco G; de Muro P; Cherchi GM; Formato M; Lepedda AJ; Cigliano A; Zinellu E; Dessole F; Gordini L; Dessole S
Arch Gynecol Obstet; 2010 Aug; 282(2):207-13. PubMed ID: 20306065
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of circulating concentrations of gonadotropins and ovarian hormones throughout the menstrual cycle in the bonnet monkey: role of inhibin A in the regulation of follicle-stimulating hormone secretion.
Suresh PS; Medhamurthy R
Am J Primatol; 2009 Oct; 71(10):817-24. PubMed ID: 19452529
[TBL] [Abstract][Full Text] [Related]
16. Influence of menstrual cycle on the pharmacokinetics of paracetamol through salivary compartment in healthy subjects.
Gugilla SR; Boinpally RR; Bolla SM; Devaraj R
Ther Drug Monit; 2002 Aug; 24(4):497-501. PubMed ID: 12142633
[TBL] [Abstract][Full Text] [Related]
17. Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteers.
Flores Pérez J; Juárez Olguín H; Flores Pérez C; Pérez Guillé G; Guillé Pérez A; Camacho Vieyra A; Toledo López A; Carrasco Portugal M; Lares Asseff I
Chronobiol Int; 2003 May; 20(3):485-94. PubMed ID: 12868543
[TBL] [Abstract][Full Text] [Related]
18. Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle.
Kletzky OA; Shangold GA
Am J Obstet Gynecol; 1986 Feb; 154(2):362-7. PubMed ID: 3080890
[TBL] [Abstract][Full Text] [Related]
19. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
